Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages 468-474

  Martín Peña, Almudena ^a   Aguilar Guisado, Manuela ^a,b   Espigado, Ildefonso ^a,b   Parody, Ricardo ^b   Miguel Cisneros, José ^a,b  

^a Spanish Network for Research Infectious Diseases ^*  (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Allogeneic stem cell; Infection; Mortality; Risk factors; Transplantation

Indexed keywords

BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; LEVOFLOXACIN; MELPHALAN; THIOTEPA; VALGANCICLOVIR;

ACUTE GASTROENTERITIS; ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIUM; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CATHETER INFECTION; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CYSTITIS; CYTOMEGALOVIRUS INFECTION; DEATH; DISEASE ASSOCIATION; FEBRILE NEUTROPENIA; FEMALE; FUNGUS; GRAFT RECIPIENT; HODGKIN DISEASE; HUMAN; IMMUNOPROPHYLAXIS; INCIDENCE; INFECTION RISK; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOULD; MYCOSIS; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; OBSERVATIONAL STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYELONEPHRITIS; RISK FACTOR; SINUSITIS; SYSTEMIC MYCOSIS; TRACHEOBRONCHITIS; VIRUS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFECTION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 79958724628     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01286.x     Document Type: Article

References (29)

1. Lysak D, Koza V, Jindra P et al. Allogeneic BMT in patients above 45years of age: a single center experience. Bone Marrow Transplant 2001: 27: 723.
2. Park SH, Choi SM, Lee DG et al. Current trends of infectious complications following hematopoietic stem cell transplantation in a single center. J Korean Med Sci 2006: 21: 199.
3. Safdar A, Rodriguez GH, De Lima MJ et al. Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine (Baltimore) 2007: 86: 324.
4. Asano-Mori Y, Kanda Y, Oshima K et al. Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation. Int J Hematol 2008: 87: 310.
5. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007: 44: 531.
6. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002: 34: 730.
7. Sullivan KM. Graft versus host disease. In: Thomas ED, Blume KG, Forman SJ eds. Hematopoietic Cell Transplantation. Malden: Blackwell Science. Inc., 1998: 515.
8. Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 1991: 78: 246.
9. Kusne S, Dummer JS, Singh N et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988: 67: 132.
10. Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006: 355: 2725.
11. Bowden RA, Meyers JD. Infection complicating bone morrow transplantation. In: Rubin RH, Young LS. Clinical Approach to Infection in the Compromised Host. New York: Plenum Medical Book Company, 1994: 601.
12. Torre-Cisneros J, Fortun J, Aguado JM et al. Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients. Enferm Infecc Microbiol Clin 2005: 23: 424.
13. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008: 46: 1813.
14. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974: 18: 295.
15. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980: 69: 204.
16. Busca A, Locatelli F, Barbui A et al. Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2003: 5: 132.
17. Frere P, Baron F, Bonnet C et al. Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplant 2006: 37: 411.
18. Yoo JH, Lee DG, Choi SM et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 2004: 34: 497.
19. Parody R, Martino R, Rovira M et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006: 12: 734.
20. Saavedra S, Jarque I, Sanz GF et al. Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution. Clin Microbiol Infect 2002: 8: 725.
21. Einsele H, Bertz H, Beyer J et al. Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003: 82: 175.
22. Ninin E, Milpied N, Moreau P et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001: 33: 41.
23. Rodriguez-Bano J, Cisneros JM, Fernandez-Cuenca F et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 2004: 25: 819.
24. Einsele H, Hebart H, Kauffmann-Schneider C et al. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant 2000: 25: 757.
25. Martino R, Caballero MD, Canals C et al. Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001: 28: 341.
26. Bjorklund A, Aschan J, Labopin M et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant 2007: 40: 1055.
27. Nucci M, Andrade F, Vigorito A et al. Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation. Transpl Infect Dis 2003: 5: 167.
28. Bacigalupo A, Sormani MP, Lamparelli T et al. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 2004: 89: 1238.
29. Gratwohl A, Brand R, Frassoni F et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 2005: 36: 757.